eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
4.110
0.00 (0.00%)
Oct 30, 2026, 9:46 AM EDT - Market open
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $38.15 million as of October 30, 2026. It is the 32,036th most valuable company in the world and the 4,793rd biggest in the United States. Its market cap has decreased by 64.04% in one year.
Market Cap
38.15M
Enterprise Value
33.58M
1-Year Change
-64.04%
Global Rank
Country Rank
#4,793 United States
Category
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $38.15M, a decrease of -45.74%. That is a compound annual growth rate of -26.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 38.15M | -58.27% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 43.46M |
| Alterity Therapeutics | 42.73M |
| Dogwood Therapeutics | 41.81M |
| Grace Therapeutics | 40.81M |
| Aldeyra Therapeutics | 39.76M |
| GridAI Technologies | 38.59M |
| Adicet Bio | 38.54M |
| Veru Inc. | 38.02M |